Seven patients with advanced gallbladder carcinoma were given intraarterial infusions of 10 to 15 mg mitomycin C with 10 to 24 days' interval, 3 received intravenous infusion (10 mg/m2) with median 3 weeks' interval. Stationary disease was obtained in 4 patients, progressive disease in 4, and treatment failures in 2. The median survival after mitomycin C treatment was 4 months (range 1-23 +). Irreversible thrombocytopenia occurred in 2 patients and a severe gastrointestinal bleeding episode in one.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3109/02841868009130137 | DOI Listing |
Publication Analysis
Top Keywords
advanced gallbladder
8
gallbladder carcinoma
8
mitomycin advanced
4
carcinoma patients
4
patients advanced
4
carcinoma intraarterial
4
intraarterial infusions
4
infusions mitomycin
4
mitomycin days'
4
days' interval
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!